Last reviewed · How we verify
Bone Grafting
At a glance
| Generic name | Bone Grafting |
|---|---|
| Sponsor | University of Sao Paulo General Hospital |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Mucositis
- Elevated transminitis
- Infections
- Hypertension
- Skin GvHD
- ATG induced fevers
- Fluid overload
- Anaemia
- Neutropenic fevers
- Diarrhea
- Upper GI GvHD
Key clinical trials
- Using Different Biomaterials to Preserve Bone After Tooth Extraction (NA)
- Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists (PHASE1, PHASE2)
- Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? (NA)
- Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- Predicting Periodontal Treatment Success Using Machine Learning in Periodontitis Patients
- Allograft vs. Autograft Nonunion (NA)
- Elamrousy Modified Approach for Socket Shield Technique (NA)
- Evaluation of the Magnesium Shield Compared to Dual Zone Grafting Approach in Immediate Implant Site Management. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bone Grafting CI brief — competitive landscape report
- Bone Grafting updates RSS · CI watch RSS
- University of Sao Paulo General Hospital portfolio CI